New Drug CagriSema May Lead to 10% More Weight Loss Than Wegovy or Ozempic
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...
Novo Nordisk affirms 25% weight-loss expectation for experimental drug CagriSema
Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...
Yahoo6d
New Drug CagriSema May Lead to 10% More Weight Loss Than Wegovy or Ozempic
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs Ozempic and Wegovy. Novo Nordisk, the manufacturer of both, recently ...
FierceBiotech1d
Gura's weekly amylin obesity asset well tolerated, tied to weight loss in phase 1 trial
GUBamy is part of the investigational amylin field, a burgeoning landscape that includes Novo Nordisk’s CagriSema, a ...
ThePrint on MSN1d
Ozempic on steroids? Successor that could cut down weight in half the time coming soon
While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...
malaymail7d
Novo Nordisk says its experimental drug CagriSema has similar side effects to Wegovy
LONDON, Nov 7 — Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar ...
FoodBusinessNews5h
Hershey acknowledges ‘mild impact’ from GLP-1 drugs
HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief ...
Baking Business3h
Hershey acknowledges ‘mild impact’ on business from GLP-1 drugs
HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief executive officer Michele Buck told analysts in a conference call on fiscal 2024 ...
Quartz on MSN8d
A new stronger Ozempic is coming. Here's what to know
Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday.